Mai Capital Management Inmune Bio, Inc. Transaction History
Mai Capital Management
- $9.87 Billion
- Q2 2024
A detailed history of Mai Capital Management transactions in Inmune Bio, Inc. stock. As of the latest transaction made, Mai Capital Management holds 160,582 shares of INMB stock, worth $990,790. This represents 0.01% of its overall portfolio holdings.
Number of Shares
160,582
Previous 181,410
11.48%
Holding current value
$990,790
Previous $2.13 Million
33.55%
% of portfolio
0.01%
Previous 0.02%
Shares
6 transactions
Others Institutions Holding INMB
# of Institutions
63Shares Held
4.78MCall Options Held
80KPut Options Held
41.8K-
Black Rock Inc. New York, NY813KShares$5.02 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA628KShares$3.88 Million0.0% of portfolio
-
Cvi Holdings, LLC Wilmington, DE596KShares$3.68 Million45.87% of portfolio
-
Praetorian Pr LLC Rincon, PR485KShares$2.99 Million1.57% of portfolio
-
Raymond James Financial Services Advisors, Inc. St. Petersburg, FL369KShares$2.28 Million0.0% of portfolio
About Inmune Bio, Inc.
- Ticker INMB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 17,946,000
- Market Cap $111M
- Description
- INmune Bio, Inc., a clinical-stage immunotherapy company, focuses on developing drugs to reprogram the patient's innate immune system to treat disease. The company develops and commercializes product candidates to treat hematologic malignancies, solid tumors, and chronic inflammation. Its development programs include INKmune, which focuses on tr...